Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Serostim recombinant human growth hormone: Began a Phase II dose-ranging study to evaluate safety and efficacy, and to find the optimal dose regimen, as well as

Serono Laboratories Inc., Norwell, Mass.
Product: Serostim

Read the full 71 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE